AML, ADULT
Clinical trials for AML, ADULT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT trials appear
Sign up with your email to follow new studies for AML, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough leukemias: targeted drug BN104 enters human trials
Disease control OngoingThis study tests a new drug called BN104 in people whose acute leukemia has come back or not responded to standard treatments. The drug targets specific genetic changes (KMT2A or NPM1 mutations) that drive the cancer. The trial aims to find the safest dose and see if BN104 can re…
Matched conditions: AML, ADULT
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Can early comfort care improve end of life for leukemia patients?
Symptom relief OngoingThis study looks at whether starting palliative care early helps adults with relapsed or high-risk leukemias or myelodysplastic syndrome. About 105 participants will be randomly assigned to receive early palliative care or usual care. The goal is to see if it improves where they …
Matched conditions: AML, ADULT
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
What matters most? study tracks quality of life in older leukemia patients
Knowledge-focused OngoingThis study looks at how different treatments affect the quality of life of people aged 60 and older who are newly diagnosed with acute myeloid leukemia (AML). Researchers will track patients' well-being using a detailed questionnaire to learn what matters most to them. The goal i…
Matched conditions: AML, ADULT
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 07:26 UTC